FIELD: biotechnology.
SUBSTANCE: Staphylococcus aureus A9 strain characterized by tolerance to ciprofloxacin, has been deposited in the State Collection of Pathogenic Microorganisms and Cell Cultures under registration number B-9982.
EFFECT: invention provides an expansion of the arsenal of tools used as a control test culture for determining sensitivity to antibiotics.
1 cl, 5 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STRAIN OF STAPHYLOCOCCUS AUREUS CHARACTERIZED BY RESISTANCE TO DAPTOMYCIN AND USED AS A CONTROL TEST CULTURE TO DETERMINE ANTIBIOTIC SENSITIVITY | 2022 |
|
RU2809847C1 |
| STAPHYLOCOCCUS AUREUS STRAINS CHARACTERIZED BY RESISTANCE TO VANCOMYCIN AND USED AS CONTROL TEST CULTURES FOR DETERMINING SENSITIVITY TO GLYCOPEPTIDE ANTIBIOTICS | 2022 |
|
RU2802896C1 |
| STRAINS OF STAPHYLOCOCCUS AUREUS (MSSA) CHARACTERIZED BY MEC-INDEPENDENT MECHANISMS OF RESISTANCE TO BETA-LACTAMS AND USED AS CONTROL TEST CULTURES TO DETERMINE THE SENSITIVITY TO BETA-LACTAM ANTIBIOTICS | 2022 |
|
RU2802895C1 |
| STRAIN OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) CHARACTERIZED BY RESISTANCE TO CEFTAROLINE AND USED AS A CONTROL TEST CULTURE TO DETERMINE SENSITIVITY TO BETA-LACTAM ANTIBIOTICS (VARIANTS) | 2022 |
|
RU2798788C1 |
| METHODS OF TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2666605C2 |
| METHOD OF EXTRACTING VIRULENT BACTERIOPHAGES STAPHYLOCOCCUS AUREUS | 2020 |
|
RU2738743C1 |
| COMBINATIONS OF BACTERIOPHAGE LYSINE AND ANTIBIOTICS AGAINST GRAM-POSITIVE BACTERIA | 2013 |
|
RU2659208C2 |
| COMPOUNDS AND METHODS OF TREATING INFECTIONS | 2014 |
|
RU2666540C2 |
| METHOD FOR ESTIMATING EFFICIENCY OF INFECTIOUS DISEASE THERAPY | 2015 |
|
RU2615417C1 |
| METHOD FOR MICRO-DILUTION IN LIQUID MEDIUM FOR EVALUATING AND DETERMINING MINIMUM INHIBITORY CONCENTRATION OF ANTIBACTERIAL POLYPEPTIDES | 2017 |
|
RU2754667C2 |
